Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Fri, 07/31/2020 - 02:44	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind Brazil newsletter		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Fri, 07/31/2020 - 02:44	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	masaru-hashimoto@cmic.co.jp manually updating trust level from 1 to 5		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 0		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 4		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER